TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

3D Systems Dives After Big Top-Line and Bottom-Line Misses
Play
INVESTING

Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday

  • By Rob Lenihan
  • Oct 7, 2020 4:27 PM EDT
PRESS RELEASES

Ocular Therapeutix™ Presents Interim Topline Data From The Phase 1 Clinical Trial Of OTX-TIC In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension At The 10th Annual Glaucoma 360 New Horizons Forum

  • By Business Wire
  • Jan 20, 2021 8:00 AM EST
PRESS RELEASES

Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, To President, Ophthalmology And Appoints Rabia Gurses Ozden, MD As Senior Vice President, Clinical Development

  • By Business Wire
  • Jan 7, 2021 8:00 AM EST
PRESS RELEASES

Ocular TherapeutixTM Announces Exercise Of Underwriters' Option To Purchase Additional Shares

  • By Business Wire
  • Dec 28, 2020 8:00 AM EST
PRESS RELEASES

Ocular Therapeutix™ Announces Submission To The FDA Of A Supplemental New Drug Application For DEXTENZA® (dexamethasone Ophthalmic Insert) For The Treatment Of Ocular Itching Associated With Allergic Conjunctivitis

  • By Business Wire
  • Dec 22, 2020 8:45 AM EST
PRESS RELEASES

Ocular TherapeutixTM Announces Pricing Of Public Offering Of Common Stock

  • By Business Wire
  • Dec 15, 2020 9:47 PM EST
PRESS RELEASES

Ocular Therapeutix™ Announces Proposed Public Offering Of Common Stock

  • By Business Wire
  • Dec 14, 2020 4:13 PM EST
PRESS RELEASES

Ocular Therapeutix™ To Present At The Piper Sandler 32nd Annual Virtual Healthcare Conference

  • By Business Wire
  • Nov 23, 2020 8:00 AM EST
PRESS RELEASES

Ocular Therapeutix™ To Present Data At The American Academy Of Ophthalmology (AAO) 2020 Virtual Annual Meeting

  • By Business Wire
  • Nov 11, 2020 9:00 AM EST
PRESS RELEASES

Ocular Therapeutix™ To Participate At Two Upcoming Investor Conferences

  • By Business Wire
  • Nov 9, 2020 4:01 PM EST
PRESS RELEASES

Ocular Therapeutix Announces Receipt Of A Permanent Category I CPT Code From The American Medical Association For The Insertion Of Intracanalicular Inserts

  • By Business Wire
  • Nov 4, 2020 8:00 AM EST
PRESS RELEASES

Ocular Therapeutix™ And AffaMed Therapeutics Announce License Agreement And Collaboration For DEXTENZA® And OTX-TIC In Asia

  • By Business Wire
  • Oct 30, 2020 8:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ To Report Third Quarter 2020 Financial Results

  • By Business Wire
  • Oct 23, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ Announces Pricing Of Public Offering Of Common Stock

  • By Business Wire
  • Oct 14, 2020 6:30 AM EDT
PRESS RELEASES

Ocular Therapeutix™ Announces Proposed Public Offering Of Common Stock

  • By Business Wire
  • Oct 13, 2020 5:01 PM EDT
3D Systems Dives After Big Top-Line and Bottom-Line Misses
INVESTING

Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday

  • By Rob Lenihan
  • Oct 7, 2020 4:27 PM EDT
PRESS RELEASES

Ocular Therapeutix™ Announces First Patients Dosed In Phase 2 Clinical Trial Of OTX-CSI For The Treatment Of Dry Eye Disease

  • By Business Wire
  • Sep 29, 2020 8:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ Announces First Patient Dosed In Phase 3 Clinical Trial Of DEXTENZA® For The Treatment Of Post-Surgical Ocular Inflammation And Pain In Children

  • By Business Wire
  • Sep 10, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ Announces Successful Resolution Of FDA Warning Letter Related To ReSure® Sealant

  • By Business Wire
  • Sep 8, 2020 7:00 AM EDT
PRESS RELEASES

(Graphic: Business Wire)

  • By Business Wire
  • Sep 4, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ To Present At Two Upcoming Investor Conferences

  • By Business Wire
  • Sep 3, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results

  • By Business Wire
  • Jul 31, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix Announces Second Medicare Administrative Contractor To Establish New Published Physician Fee Schedule For Administration Of Intracanalicular Inserts

  • By Business Wire
  • Jul 23, 2020 7:00 AM EDT
PRESS RELEASES

Ocular Therapeutix Presents At The 12th Annual Ophthalmology Innovation Summit (OIS)

  • By Business Wire
  • Jul 17, 2020 7:30 AM EDT
PRESS RELEASES

Ocular Therapeutix™ To Present Data At The Association For Research In Vision And Ophthalmology (ARVO) Annual Meeting

  • By Business Wire
  • Jun 15, 2020 8:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.